On Friday, Archbishop Naumann said that the FDA is right to regulate chemical abortions, which if prescribed and dispensed remotely could carry special health risks for women.
Results from Tag: 'fda'
The American College of Obstetricians and Gynecologists and other pro-abortion groups pushed for the restrictions to be lifted during the COVID-19 pandemic so women would not have to travel to get the abortion pill.
The normal requirement of the Food and Drug Administration (FDA), in place since 2000, is that the abortion pill be dispensed and administered in-person.
The FDA has recorded 24 deaths of women associated with the drugs, as well as more than 4,000 cases with adverse effects since 2000.
Since 2000, the FDA has placed the chemical abortion protocol of mifepristone and misoprostol—allowed in the U.S. for abortions up to 10 weeks in a pregnancy—under its Risk Evaluation and Mitigation Strategy (REMS) list, requiring it to be prescribed in-person in a hospital, clinic, or medical office.
During the coronavirus pandemic, abortion advocates have cited a reduction in in-person doctor appointments for elective procedures as a reason for the FDA to allow the pill to be prescribed remotely via telemedicine.
Approximately 39,000 women filed claims saying they were injured by the device, which is a metal coil that is inserted in a fallopian tube.
Signers of the letter include Marjorie Dannenfelser, president of the Susan B. Anthony List; Jeanne Mancini, president of March for Life; Catherine Glenn Foster, president and CEO of Americans United for Life; Ryan Bomberger, co-founder of the Radiance Foundation; and Russell Moore, president of the Southern Baptist Ethics and Religious Liberty Commission.
The pro-life coalition included Marjorie Dannenfelser, president of the Susan B. Anthony List, Kristan Hawkins, president of Students for Life of America, Lila Rose, president and founder of Live Action, and Jeanne Mancini, president of March for Life.
The FDA allows for chemical abortions, but requires that a certified prescriber dispense the two drug regimen of RU-486 and misoprostol after confirming the gestational age to be not more than 10 weeks and ruling out an ectopic pregnancy.